BSEAGM/EGM1 Sept 2026 · 1 Sept 2026, 05:24 pm

Notice of Annual General Meeting and Annual Report 2025-26

Nath Bio-Genes (India) Ltd · 537291

✦ AI SummaryResults

Nath Bio-Genes (India) Ltd has announced its 33rd Annual General Meeting (AGM) and Annual Report for the financial year 2025-26. The AGM will be held on September 24, 2026, through video conferencing. The company will consider adopting the audited financial statements, declaring a final dividend of ₹ 2 per equity share, and re-appointing a director retiring by rotation.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Nath Bio-Genes (India) Ltd - 537291 - Intimation Of Annual General Meeting

Attachments (1)

📄

715a618b-ae82-40c3-81ff-45a92c191ddf.pdf

pdf

Download →
View document text
01st September 2026 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeeb hoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code- 537291 NSE Code-NATHBIOGEN Sub: Submission of Notice of Annual General Meeting and Annual Report for the financial year 2025- Ref: Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, With reference to the captioned subject, we are submitting herewith the Notice of the 33rd Annual General Meeting (AGM) of the Company along with the Integrated Annual Report of the Company for the financial year 2025-26, which is being sent to the shareholders by electronic mode. The 33rd Annual General Meeting of the Company will be held on Thursday, 24th September 2026 at 11.00 a.m. through Video Conferencing/Other Audio Visual Means (VC/OAVM). Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is pleased to provide its Members with the remote e- voting facility to cast their votes electronically on the resolutions mentioned in the AGM Notice using the electronic voting platform provided by National Securities Depository Limited (NSDL). The voting rights of Members shall be in proportion to the shares held by them, as on the cut-off date i.e. Friday, 11th September 2026. The remote e-voting period commences on Monday, 21st September 2026 at 9.00 a.m. and ends on Wednesday, 23rd September 2026 at 5.00 p.m. The remote e-voting module shall be disabled by NSDL for voting thereafter. In addition, the facility for voting through electronic voting system shall also be made available at the AGM and the Members participating in the AGM through VC/OAVM, who have not already cast their vote by remote e-voting, shall be able to exercise their voting rights in the meeting. Kindly take the same on your record. Please take the above on record and oblige. Thanking you, Yours faithfully, For Nath Bio-Genes (India) Limited Amol Arunrao Digitally signed by Amol Arunrao Gupta Gupta Date: 2026.09.01 16:18:43 +05'30' Amol Gupta Chief Financial Officer 33 ANNUAL REPORT 2025-26 CORPORATE INFORMATION Directors Mr. Sa(cid:415)sh Kagliwal - Managing Director Mrs. Jeevanlata Kagliwal Mr. Akash Kagliwal Mr. Hitesh Purohit Mr. Vadla Nagabhushanam Mr. Madhukar Deshpande Ms. Payal Jain Chief Financial O(cid:312)cer Mr. Amol Gupta Company Secretary Mr. Dhiraj Rathi Statutory Auditors Gautam N Associates Chartered Accountant 30, GNA House, Behind ABC Complex, Manmandir Travels Lane, Adalat Road, Aurangabad-431 001 Bankers 1. Axis Bank 2. Janakalyan Sahakari Bank Ltd. 3. HDFC Bank Ltd. 4. State Bank of India. Registered O(cid:312)ce Nath House, Nath Road, Chh. Sambhajinagar-431005 0240-6645555 Corporate O(cid:312)ce 1, Chateau Windsor 86, Veer Nariman Road Churchgate, Mumbai – 400 020 Registrar & Transfer Agents Big Share Service Private Limited, O(cid:312)ce NoS6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Center, Mahakali caves Road, Andheri East, Mumbai-400 059. CONTENTS Sr. No. No(cid:415)ce Page No. 1 No(cid:415)ce of Annual General Mee(cid:415)ng 1 2 Managing Director’s Statement 20 3 Director’s Report 22 4 Management Discussion & Analysis Report 56 5 Corporate Governance Report 66 6 Independent Auditor’s Report (Standalone) 100 7 Financial Statement (Standalone) 112 8 Independent Auditor’s Report (Consolidated) 142 9 Financial Statement (Consolidated) 150 NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given that the thirty-three annual general meeting of Nath bio-genes (India) Limited will be held on Thursday, 24th September 2026 at 11.00 a.m. IST through video conferencing (vc)/ other means (oavm) to transact the following business: ORDINARY BUSINESS. 1. ADOPTION OF FINANCIAL STATEMENTS. To receive, consider and adopt the Audited Balance Sheet of the Company as of March 31, 2026, and Statement of Profit & Loss for the year ended as on that date together with the Reports of Directors and Auditors thereon. To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT the audited Standalone Financial Statement of the Company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and the Statutory Auditor thereon, be and are hereby received, considered and adopted.” “RESOLVED THAT the audited Consolidated Financial Statement of the Company for the financial year ended 31st March, 2026, together with the Report of the Statutory Auditor thereon, be and are hereby received, considered and adopted.” 2. DECLARATION OF DIVIDEND. To declare a final Dividend of ₹ 2 per equity shares of face value of ₹ 10 each for financial year ended 31st March 2026. To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT as recommended by the Board of Directors, dividend for the financial year 2025- 26 at the rate of ₹ 2 per equity shares of face value of ₹ 10 each, be and is hereby declared and that the said dividend be paid out of the profits of the Company to the eligible equity shareholders.” 3. RE-APPOINTMENT OF DIRECTOR RETIRING BY ROTATION. To appoint Mrs. Jeevanlata Kagliwal (DIN-02057459) as Director of the Company, who retires by rotation and being eligible, offer herself for re-appointment. To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution RESOLVED THAT in accordance with the provisions of Section 152 and other applicable provisions, if any, of the Companies Act, 2013, including any statutory modification(s) or re-enactment thereof for the time being in force, Mrs. Jeevanlata Kagliwal (DIN: 02057459), who retires as a Director by rotation and, being eligible, has offered herself for re appointment, be and is hereby re-appointed as a Director of the Company.” 11 // 118821 SPECIAL BUSINESS 4. RE-APPOINTMENT OF MR. HITESH RAJNIKANT PUROHIT AS INDEPENDENT DIRECTOR OF THE COMPANY To consider, and if thought fit, to pass the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions of the Companies Act, 2013, the Companies (Appointment and Qualification of Directors) Rules, 2014 read with Schedule IV to the Companies Act, 2013 and Regulation 16(1)(b), 17, 25 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof) and the provisions of the Articles of Association of the Company, and based on the performance evaluation, recommendation of the Nomination and Remuneration Committee and approval of the Board of Directors at their respective Meeting held on 04th May, 2026, Mr. Hitesh Rajnikant Purohit (DIN: 02340858), who has submitted a declaration that he meets the criteria of independence as provided under Section 149(6) of the Companies Act, 2013 and the Rules made thereunder and Regulation 16(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and is eligible for re-appointment, and in respect of whom the Company has received a notice in writing under Section 160 of the Companies Act, 2013 proposing his candidature for the office of Independent Director, be and is hereby re-appointed as an Independent Director of the Company for a second term of five consecutive years with effect from 30th March, 2027 to 29th March, 2032, and that he shall not be liable to retire by rotation. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorized to do all such acts, deeds, matters and things and execute all such document [Showing first 8,000 characters — download PDF for full document]